digital health investment

Plexāā, maker of the Bloom medical device for breast surgery, scores $4.5 million in funding.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.

The investment will accelerate Nexus IT’s U.S. expansion and support acquisitions of culturally aligned MSPs in healthcare and other regulated industries.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.

The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.

The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.